These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2696044)

  • 1. New information on drug resistance: implications for the adjuvant treatment of breast cancer.
    Goldie JH
    Recent Results Cancer Res; 1989; 115():8-16. PubMed ID: 2696044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin: a review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer.
    Ormrod D; Holm K; Goa K; Spencer C
    Drugs Aging; 1999 Nov; 15(5):389-416. PubMed ID: 10600046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy in early breast cancer.
    Chittoor SR; Swain SM
    Am Fam Physician; 1991 Aug; 44(2):453-62. PubMed ID: 1858602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic breast cancer: treatment with fluorouracil-based combinations.
    Klaassen U; Seeber S
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):69-73. PubMed ID: 9348573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving concepts in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to the treatment of advanced breast cancer.
    Eckardt JR
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():41-6. PubMed ID: 8862711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of adjuvant chemotherapy in the choice of chemotherapeutic treatment of metastatic breast cancer].
    Lopez M; Di Lauro L; Viola G; Conti F; Foggi P; Vici P
    Clin Ter; 2009; 160(6):489-97. PubMed ID: 20198293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance and cancer chemotherapy strategy in breast cancer.
    Goldie JH
    Breast Cancer Res Treat; 1983; 3(2):129-36. PubMed ID: 6351948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a standard type and duration of adjuvant chemotherapy for early stage breast cancer?
    Hayes DF
    Breast; 2009 Oct; 18 Suppl 3():S131-4. PubMed ID: 19914531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic breast cancer: what are the objectives?].
    Salvini P; Ripa C; Ginanni V
    Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of chemotherapy in metastatic breast cancer.
    Garber JE; Henderson IC
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):807-21. PubMed ID: 2481671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of breast cancer: current views and results.
    Bonadonna G; Valagussa P
    Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):279-97. PubMed ID: 6341335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dense and sequential strategies in adjuvant breast cancer therapy.
    Untch M; Von Koch F; Crohns C; Sobotta K; Kahlert S; Konecny G; Hepp H
    Oncology (Williston Park); 2001 May; 15(5 Suppl 7):14-20. PubMed ID: 11396359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of adjuvant therapy in colorectal cancer.
    Hesketh PJ; Bulger KN
    Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.